Aakaar Medical Technologies Ltd
Incorporated in June 2013, Aakaar Medical Technologies Limited is an aesthetic medical company that offers a diverse selection of specialized cosmetic products and devices.[1]
- Market Cap ₹ 97.8 Cr.
- Current Price ₹ 69.0
- High / Low ₹ 105 / 46.0
- Stock P/E 14.7
- Book Value ₹ 38.5
- Dividend Yield 0.00 %
- ROCE 18.5 %
- ROE 17.1 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 65.2% CAGR over last 5 years
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 203 days.
- Working capital days have increased from 130 days to 199 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Fast Moving Consumer Goods Fast Moving Consumer Goods Personal Products Personal Care
Part of Nifty SME Emerge
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| 22.89 | 12.44 | 19.47 | 32.78 | 46.11 | 61.58 | 66.96 | |
| 20.01 | 11.54 | 17.07 | 29.25 | 41.11 | 51.84 | 56.64 | |
| Operating Profit | 2.88 | 0.90 | 2.40 | 3.53 | 5.00 | 9.74 | 10.32 |
| OPM % | 12.58% | 7.23% | 12.33% | 10.77% | 10.84% | 15.82% | 15.41% |
| 0.12 | 0.12 | 0.04 | 0.09 | 0.16 | 0.18 | 0.80 | |
| Interest | 0.46 | 0.23 | 0.21 | 0.43 | 1.14 | 1.71 | 1.80 |
| Depreciation | 0.04 | 0.03 | 0.02 | 0.09 | 0.14 | 0.12 | 0.13 |
| Profit before tax | 2.50 | 0.76 | 2.21 | 3.10 | 3.88 | 8.09 | 9.19 |
| Tax % | 26.80% | 28.95% | 26.24% | 30.65% | 26.29% | 25.22% | 27.86% |
| 1.83 | 0.54 | 1.62 | 2.15 | 2.87 | 6.04 | 6.64 | |
| EPS in Rs | 183.00 | 54.00 | 23.14 | 30.71 | 41.00 | 5.80 | 4.69 |
| Dividend Payout % | 0.00% | 0.00% | 34.57% | 24.42% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 40% |
| 3 Years: | 27% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 65% |
| 3 Years: | 46% |
| TTM: | 10% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 10% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 23% |
| 3 Years: | 23% |
| Last Year: | 17% |
Balance Sheet
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.10 | 0.10 | 0.70 | 0.70 | 0.70 | 10.42 | 14.17 |
| Reserves | 6.75 | 7.30 | 7.33 | 8.96 | 11.84 | 12.78 | 40.38 |
| 5.88 | 3.88 | 3.82 | 5.87 | 15.05 | 22.74 | 18.53 | |
| 3.56 | 3.03 | 6.15 | 7.70 | 6.42 | 8.17 | 6.34 | |
| Total Liabilities | 16.29 | 14.31 | 18.00 | 23.23 | 34.01 | 54.11 | 79.42 |
| 0.06 | 0.04 | 0.20 | 0.36 | 0.28 | 0.24 | 0.69 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.47 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 15.76 | 14.16 | 17.80 | 22.87 | 33.73 | 53.87 | 78.73 | |
| Total Assets | 16.29 | 14.31 | 18.00 | 23.23 | 34.01 | 54.11 | 79.42 |
Cash Flows
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| -0.38 | 4.31 | 0.48 | -2.93 | -8.04 | -5.41 | -8.36 | |
| 0.10 | 0.37 | -0.23 | -0.32 | -0.04 | -0.05 | 0.05 | |
| 0.28 | -2.00 | -0.81 | 1.17 | 8.19 | 10.71 | 18.80 | |
| Net Cash Flow | 0.00 | 2.68 | -0.55 | -2.08 | 0.11 | 5.25 | 10.48 |
| Free Cash Flow | -0.40 | 4.30 | 0.29 | -3.19 | -8.09 | -5.49 | -8.94 |
| CFO/OP | 10% | 503% | 47% | -54% | -136% | -35% | -59% |
Ratios
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 117.84 | 135.85 | 104.42 | 113.91 | 128.71 | 165.96 | 202.94 |
| Inventory Days | 234.33 | 366.16 | 281.70 | 273.75 | 247.29 | 202.47 | 255.63 |
| Days Payable | 28.20 | 98.96 | 65.19 | 61.56 | 31.74 | 48.84 | 24.33 |
| Cash Conversion Cycle | 323.97 | 403.05 | 320.92 | 326.10 | 344.26 | 319.59 | 434.24 |
| Working Capital Days | 189.44 | 238.25 | 105.17 | 101.55 | 93.96 | 96.85 | 198.91 |
| ROCE % | 8.25% | 20.93% | 25.79% | 23.28% | 26.66% | 18.47% |
Insights
In beta| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Number of Doctors Using Multiple Brands (Cross-sell Total) count |
|
||||
| Number of Field Force (MR Executives) count |
|||||
| Number of SKUs count |
|||||
| Own Brand Share of Revenue % |
|||||
| Top 10 Own Products Share of Revenue % |
|||||
| Number of Customers (Doctors/Clinics Billed) count |
|||||
| Number of Stockists count |
|||||
Extracted by Screener AI
Documents
Announcements
-
Shareholders meeting
1 July 2026 - 13th AGM on 30 Jun 2026 passed 5 resolutions, including ESOP and authorized share capital increase.
-
Amendment to AOA/MOA
30 June 2026 - 13th AGM held on 30 June 2026; shareholders approved ESOP 2026, higher authorised capital, and secretarial auditor appointment.
-
Change in Auditors
30 June 2026 - 13th AGM held on 30 June 2026; shareholders approved financials, ESOP 2026, higher authorised capital, and auditor appointment.
-
Shareholders meeting
30 June 2026 - 13th AGM held on June 30, 2026; shareholders approved ESOP 2026, director reappointment, and authorized capital hike to Rs.15.40 crore.
-
Analysts/Institutional Investor Meet/Con. Call Updates
22 June 2026 - Submitted investor presentation for 23 June 2026 analyst meeting; FY26 revenue Rs67 crore, PAT Rs6.63 crore.
Annual reports
Concalls
-
Jun 2026TranscriptAI SummaryPPT
-
May 2026Transcript PPT REC
-
Nov 2025Transcript PPT
Business Profile[1]
Aakaar Medical Technologies operates in the medical aesthetics segment, offering a portfolio of aesthetic products and devices through a B2B model. It caters primarily to dermatologists, plastic surgeons, and aesthetic physicians across India.